Related Experiment Video
Updated: Aug 17, 2025
Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Pyroptosis: A new insight of non-small-cell lung cancer treatment
Xi Chen1, Jianzhang Wu2, Jiabing Wang3
1School of Medical College, Taizhou University, Taizhou, Jiaojiang, Zhejiang, China.
Abstract:
Non-small cell lung cancer (NSCLC) has become one of the most common malignant tumors. Emerging evidence has shown that tumor resistance to apoptosis by damaging or bypassing apoptotic cell death is a major contributor to poor responses to therapy in patients with NSCLC. Pyroptosis is a new type of cytolytic and inflammatory programmed death distinct from apoptosis. Currently, pyroptosis has been reported to cause a strong inflammatory response and significant tumor suppression. It is considered a promising therapeutic strategy and prognosis for NSCLC. In this review, we summarized the characteristics of pyroptosis from its underlying basis and role in NSCLC, thereby providing the potential of pyroptosis as a therapeutic strategy and highlighting the challenges of activating pyroptosis in NSCLC treatment.
Insights
Pyroptosis, a distinct cell death, shows promise for treating non-small cell lung cancer (NSCLC). Understanding pyroptosis mechanisms could overcome therapy resistance in NSCLC patients.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
- Therapeutic resistance in NSCLC is often linked to tumor cells evading apoptosis.
- Pyroptosis, a novel programmed cell death pathway, induces inflammation and tumor suppression.
Purpose of the Study:
- To review the fundamental mechanisms of pyroptosis.
- To explore the role and therapeutic potential of pyroptosis in NSCLC.
- To identify challenges in activating pyroptosis for NSCLC treatment.
Main Methods:
- Literature review of pyroptosis and NSCLC research.
- Analysis of pyroptosis pathways and their impact on NSCLC.
- Synthesis of current understanding and future directions.
Main Results:
- Pyroptosis is a distinct inflammatory cell death pathway.
- Pyroptosis exhibits significant tumor suppressive effects in NSCLC models.
- Evidence suggests pyroptosis can overcome resistance to conventional therapies.
Conclusions:
- Pyroptosis represents a promising therapeutic strategy for NSCLC.
- Targeting pyroptosis may enhance treatment efficacy and improve prognosis in NSCLC.
- Further research is needed to overcome challenges in clinical pyroptosis activation for NSCLC.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:56Treatment Resistant Cancers